COVID19: Nigeria continues with Chroloquine trials

COVID19: Nigeria continues with Chroloquine trials

  • Post published:May 27, 2020
  • Post category:News
Share this post here.

Barely 24  hours after the World Health Organisation, WHO, suspended all clinical trials for hydroxychloroquine as a potential treatment for COVID-19, the National Agency for Food and Drug Administration and Control, NAFDAC, has said the trial will continue in Nigeria. The Director-General of the agency, Mojisola Adeyeye, stated this yesterday in an interview on a private television station.

The UN agency had on Monday said it had ‘temporarily’ suspended the clinical trials of hydroxychloroquine as a potential treatment for COVID-19 over safety concerns, adding that the decision followed a study in The Lancet that the use of the drug on COVID-19 patients could increase their likelihood of dying.

Read more


Share this post here.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments